Literature DB >> 2448427

Factors affecting the prognosis of primary liver carcinoma.

F M Sutton1, N C Russell, V F Guinee, E Alpert.   

Abstract

Analysis of the clinical records of 163 patients with primary liver carcinoma was performed to identify factors affecting prognosis. The overall 3-year survival rate was 10%, and the median survival was 7.8 months. Survival was similar for patients with single or multiple tumor nodules. There was no significant association between nodule size of 3 cm or larger and survival. Patients who underwent resection had a longer survival. For patients without cirrhosis, location of the tumor in the left lobe regardless of whether it is resected appears to be a prognostic factor associated with prolonged survival. Female sex and the absence of cirrhosis were also associated with longer survival.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2448427     DOI: 10.1200/JCO.1988.6.2.321

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  6 in total

1.  Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital.

Authors:  Pasiri Sithinamsuwan; Teerha Piratvisuth; Wiwatana Tanomkiat; Nualta Apakupakul; Surat Tongyoo
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis.

Authors:  S Ko; Y Nakajima; H Kanehiro; M Hisanaga; Y Aomatsu; T Kin; K Yagura; T Ohyama; K Nishio; K Ohashi; M Sho; T Yamada; H Nakano
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

Review 3.  [Liver resections for primary liver malignancies. Personal results and analysis of the literature].

Authors:  J Zieren; H U Zieren; J M Müller
Journal:  Langenbecks Arch Chir       Date:  1994

4.  Multimodality treatment for patients with hepatocellular carcinoma: analysis of prognostic factors in a single Western institution series.

Authors:  H Medina-Franco; M T Sellers; D E Eckhoff; J S Bynon; M M Urist; M J Heslin
Journal:  J Gastrointest Surg       Date:  2001 Nov-Dec       Impact factor: 3.452

5.  The retrovirus-mediated antisense human telomerase RNA (hTR) gene limits the growth of hepatocellular carcinoma growth in cell culture and animals.

Authors:  Ji-yong Liu; Qiang Zhu; Jianfeng Li; Shulei Zhao; Luning Li
Journal:  Dig Dis Sci       Date:  2007-10-12       Impact factor: 3.199

6.  Combined cis-platinum and alpha interferon therapy of advanced hepatocellular carcinoma.

Authors:  S K Ji; N H Park; H M Choi; Y W Kim; S H Lee; K H Lee; S Y Ahn; S U Lee; B H Han; B C Park
Journal:  Korean J Intern Med       Date:  1996-01       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.